These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8147953)

  • 21. [New Japanese GCP--from the standpoint of a sponsor].
    Ebi O
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Report on the experience of clinical trials performed according to GCP].
    Lörinczi K
    Acta Pharm Hung; 1997 Jul; 67(4):137-9. PubMed ID: 9289941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New recommendations for evaluating the effectiveness of treatment of solid tumors and principles of the Guidelines for Clinical Practice (GCP)].
    Gorbunova VA; Orel NF; Zaruk VA
    Vopr Onkol; 2001; 47(6):718-21. PubMed ID: 11826496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality control in clinical trials].
    Fukushima M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):172-82. PubMed ID: 8611045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improving the infrastructure for clinical trials in Japan].
    Nakano S
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conducting clinical trials in Singapore.
    Woo KT
    Singapore Med J; 1999 Apr; 40(4):310-3. PubMed ID: 10487091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Good clinical practices in clinical trials: the responsibility of the researcher. A survey of 827 hospital physicians (I). Availability. Monitoring. Safety. Contract].
    Dal-Ré R
    Med Clin (Barc); 1993 Mar; 100(9):346-50. PubMed ID: 8455413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Audit of clinical trials in Argentina. Assessment of standardized operational procedures in 12 centers].
    Forti IN; Barousse AP; Bernabó JG
    Medicina (B Aires); 1991; 51(6):511-8. PubMed ID: 7476103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
    Jaillon P
    Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trials in Dakar: survey on knowledge, attitudes and practices of key actors on the period from 2003 to 2007].
    Dièye AM; Gueye I; Sy GY; Ndiaye M; Ndiaye-Sy A; Faye B
    Therapie; 2008; 63(2):89-96. PubMed ID: 18561881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacy standards for clinical trials].
    Terkola R
    Onkologie; 2008; 31 Suppl 2():25-8. PubMed ID: 18487865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Good clinical practice:impediment of source of progress?].
    Dormont J
    Rev Prat; 2000 Apr; 50(8):856-61. PubMed ID: 10874863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #1: processes and requirements.
    Schwarz AJ; Becerra L; Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Evelhoch J; Hargreaves R; Robertson B; Iyengar S; Tauscher J; Bleakman D; Borsook D
    Drug Discov Today; 2011 Jul; 16(13-14):583-93. PubMed ID: 21635967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.